ATE111482T1 - N-phenylglycinderivate, ihre herstellung und medikamente, die sie enthalten. - Google Patents

N-phenylglycinderivate, ihre herstellung und medikamente, die sie enthalten.

Info

Publication number
ATE111482T1
ATE111482T1 AT91905832T AT91905832T ATE111482T1 AT E111482 T1 ATE111482 T1 AT E111482T1 AT 91905832 T AT91905832 T AT 91905832T AT 91905832 T AT91905832 T AT 91905832T AT E111482 T1 ATE111482 T1 AT E111482T1
Authority
AT
Austria
Prior art keywords
radical
optionally substituted
pct
phenyl
sec
Prior art date
Application number
AT91905832T
Other languages
English (en)
Inventor
Jean-Dominique Bourzat
Marc Capet
Claude Cotrel
Claude Guyon
Franco Manfre
Gerard Roussel
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9002889A external-priority patent/FR2659334B1/fr
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Application granted granted Critical
Publication of ATE111482T1 publication Critical patent/ATE111482T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT91905832T 1990-03-07 1991-03-05 N-phenylglycinderivate, ihre herstellung und medikamente, die sie enthalten. ATE111482T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9002889A FR2659334B1 (fr) 1990-03-07 1990-03-07 Derives de n-phenyl glycinamide, leur preparation et les medicaments les contenant.
FR909012727A FR2667864B2 (fr) 1990-03-07 1990-10-16 Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant.

Publications (1)

Publication Number Publication Date
ATE111482T1 true ATE111482T1 (de) 1994-09-15

Family

ID=26227911

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91905832T ATE111482T1 (de) 1990-03-07 1991-03-05 N-phenylglycinderivate, ihre herstellung und medikamente, die sie enthalten.

Country Status (18)

Country Link
US (1) US5475106A (de)
EP (1) EP0518960B1 (de)
JP (1) JPH05504967A (de)
AT (1) ATE111482T1 (de)
AU (1) AU635832B2 (de)
CA (1) CA2074375A1 (de)
DE (1) DE69104034T2 (de)
DK (1) DK0518960T3 (de)
ES (1) ES2059128T3 (de)
FR (1) FR2667864B2 (de)
HU (1) HUT61576A (de)
IE (1) IE65296B1 (de)
IL (1) IL97476A (de)
NO (1) NO923456D0 (de)
NZ (1) NZ237341A (de)
PT (1) PT96969B (de)
RU (1) RU2076108C1 (de)
WO (1) WO1991013907A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658518B1 (fr) * 1990-02-19 1992-04-30 Rhone Poulenc Sante N-phenyl n-alcoxycarbonylalkyle glycinamides, leur preparation et les medicaments les contenant.
JPH05504968A (ja) * 1990-03-07 1993-07-29 ローン―プーラン・ロレ・ソシエテ・アノニム グリシンアミド誘導体、その製造及びそれを含む医薬品
FR2695642A1 (fr) * 1992-09-11 1994-03-18 Rhone Poulenc Rorer Sa Dérivé d'uréido-acétamide optiquement actif, sa préparation et les médicaments les contenant.
FR2695641B1 (fr) * 1992-09-11 1994-11-25 Rhone Poulenc Rorer Sa (Amino-3 phényl)-1 éthanesulfonate d'hydroquinine optiquement actif, sa préparation et son utilisation.
FR2695640B1 (fr) * 1992-09-11 1994-11-25 Rhone Poulenc Rorer Sa Dérivés d'(amino-3 phényl)-1 éthanesulfonate d'alkylammonium optiquement actifs, leur préparation et leur utilisation.
FR2695643B1 (fr) * 1992-09-11 1994-11-25 Rhone Poulenc Rorer Sa Dérivés d'uréido-acétamide, leur préparation et les médicaments les contenant.
FR2700165B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
FR2700166B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
EP0739903B1 (de) * 1994-02-09 2002-01-23 Shionogi & Co., Ltd. Carbamoylmethylharnstoffderivate
US5756502A (en) * 1994-08-08 1998-05-26 Warner-Lambert Company Quinazolinone derivatives as cholyecystokinin (CCK) ligands
FR2723739B1 (fr) * 1994-08-19 1997-02-14 Sanofi Sa Derives de glycinamide, procedes pour leur preparation et medicaments les contenant.
GB9420763D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc Acetamide derivatives
ATE206109T1 (de) * 1995-08-07 2001-10-15 Shionogi & Co Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
FR2744364B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application d'ureidoacetamides a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
EP1007546B1 (de) * 1997-08-27 2009-01-21 Novartis Vaccines and Diagnostics, Inc. Molekular-mimetika von meningokokkus b epitopen
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
AR054321A1 (es) * 2005-01-10 2007-06-20 Bristol Myers Squibb Co Derivados en fenilglicinamida utiles como anticoagulantes
DE602006011752D1 (de) * 2005-06-24 2010-03-04 Bristol Myers Squibb Co Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
US11596612B1 (en) 2022-03-08 2023-03-07 PTC Innovations, LLC Topical anesthetics

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515744A (en) * 1966-01-07 1970-06-02 Basf Ag Substituted n-phenyl carbamates
US4055414A (en) * 1976-03-11 1977-10-25 Monsanto Company Herbicidal composition and method of use
MA19111A1 (fr) * 1979-10-26 1981-12-31 Ciba Geigy Ag Derives de l'homoserine,procede pour leur preparation et leur utilisation en tant que microbicides
US4377587A (en) * 1980-07-25 1983-03-22 Ciba-Geigy Corporation Arylamine derivatives and use thereof as microbicides
US4448773A (en) * 1981-04-29 1984-05-15 Ciba-Geigy Corporation Microbicidal N-alkoxycarbonyl-alkyl-N-substituted acetyl-anilines and -naphthylamines
US4492683A (en) * 1982-08-06 1985-01-08 Buffalo Color Corporation Method for inhibiting the growth of fungi with phenyl glycine compounds
DE3414881A1 (de) * 1984-04-19 1985-10-24 Bayer Ag, 5090 Leverkusen Allophanat-derivate
EP0166355A2 (de) * 1984-06-26 1986-01-02 Merck & Co. Inc. Substituierte Aminophenyl- und Acylaminophenyl-Verbindungen und deren pharmazeutische Zusammensetzungen
EP0175498A2 (de) * 1984-08-23 1986-03-26 The Administrators Of The Tulane University Educational Fund Peptide, deren Verwendung in der Heilkunde und Verfahren zu deren Herstellung
FR2646847B1 (fr) * 1989-05-12 1991-07-12 Rhone Poulenc Sante N-phenyl amides, leurs procedes de preparation et les medicaments les contenant
FR2658518B1 (fr) * 1990-02-19 1992-04-30 Rhone Poulenc Sante N-phenyl n-alcoxycarbonylalkyle glycinamides, leur preparation et les medicaments les contenant.
FR2659653B1 (fr) * 1990-03-13 1992-05-22 Rhone Poulenc Sante Derives de l'uree, leur preparation et les medicaments les contenant.
US5324747A (en) * 1992-07-15 1994-06-28 Hoffmann-La Roche Inc. N-substituted anilines, inhibitors of phospholipases A2

Also Published As

Publication number Publication date
WO1991013907A1 (fr) 1991-09-19
DE69104034D1 (de) 1994-10-20
DE69104034T2 (de) 1995-01-26
IL97476A (en) 1996-07-23
FR2667864B2 (fr) 1994-08-05
IL97476A0 (en) 1992-06-21
JPH05504967A (ja) 1993-07-29
US5475106A (en) 1995-12-12
NZ237341A (en) 1992-07-28
AU7492091A (en) 1991-10-10
PT96969A (pt) 1991-10-31
PT96969B (pt) 1998-07-31
AU635832B2 (en) 1993-04-01
ES2059128T3 (es) 1994-11-01
IE65296B1 (en) 1995-10-18
HUT61576A (en) 1993-01-28
FR2667864A2 (fr) 1992-04-17
EP0518960B1 (de) 1994-09-14
DK0518960T3 (da) 1994-10-17
NO923456L (no) 1992-09-04
RU2076108C1 (ru) 1997-03-27
NO923456D0 (no) 1992-09-04
HU9202865D0 (en) 1992-11-30
IE910746A1 (en) 1991-09-11
EP0518960A1 (de) 1992-12-23
CA2074375A1 (fr) 1991-09-08

Similar Documents

Publication Publication Date Title
ATE111482T1 (de) N-phenylglycinderivate, ihre herstellung und medikamente, die sie enthalten.
ATE104989T1 (de) N-phenyl-n-acetamidoglycinamide, ihre herstellung und medikamente, die sie enthalten.
DE69130830D1 (de) Insektizide, akarizide und fungizide aminopyrimidine
DE69103636D1 (de) Biaromatische verbindungen und ihre anwendung in menschen- und tierheilkunde und in der kosmetik.
DE69104475D1 (de) Harnstoffderivate, ihre herstellung und deren enthaltende arzneimittel.
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
ATE80384T1 (de) Sulfurierte eicosanoide und deren verwendung in arzneimitteln und kosmetika.
ES2094545T3 (es) Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc..
ES2136947T3 (es) Amidas triciclicas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen.
IL97357A0 (en) Propanamines,pharmaceutical compositions containing them,their application for therapeutic,in particular antidiarrhoeal purposes
ATE99326T1 (de) N-phenyl-n-alkoxycarbonylalkyl-glycinamide, ihre herstellung und sie enthaltende medikamente.
DE69117879T2 (de) Arzneimittel für die Verhütung und Behandlung von Krankheiten der Kreislauforgane enthaltend Spiro-3-heteroazolidin-Verbindungen